The Story of Influenza Antivirals: Part 10

The TOC

We decided to meet at New College in Oxford at the end of September 2010 to determine how to take the review forward. We were juggling several sources of information: publications which we mistrusted, module 1 of the Clinical Study Reports made available by Roche, and the FDA reviewers’ comments contained in documents called Medical Officer Reports (MOR…